查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575498

酵素法 DNA 合成市场：按技术、成分和应用分类 - 2025-2030 年全球预测

Enzymatic DNA Synthesis Market by Technology (Liquid-Phase Synthesis, Microchip-Based Synthesis, PCR Based Enzymatic Synthesis), Component (Reagents), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

酵素法 DNA 合成市场 2023 年估值为 48.7 亿美元，预计到 2024 年将达到 53.7 亿美元，复合年增长率为 10.51%，预计到 2030 年将达到 98.2 亿美元。

酶促 DNA 合成是一种创新的生物技术，可利用酶催化反应促进 DNA 序列的生产，比传统化学合成方法提供更高的精度和效率。对酵素法 DNA 合成的需求源于个人化医疗、合成生物学和基因疗法中的应用，并且受到对快速、高保真 DNA 构建日益增长的需求的推动。其应用范围扩展到实验室、製药公司和农业生物技术公司，这些领域的高通量和特异性非常重要。最终用途范围涵盖学术和工业部门，专门从事基因工程、诊断和药物开发。市场成长受到不断扩大的基因组学市场、生物技术研究投资的增加以及对永续和可扩展的 DNA 合成方法的需求的影响。酶工程和自动化的进步正在提高合成能力，并为公司提供差异化解决方案创造机会。向环境友善生物技术製程的转变凸显了绿色合成技术的潜在机会。挑战包括与酵素工程相关的技术挑战、大规模生产的成本效益问题以及医疗保健应用中的监管障碍。此外，克服智慧财产权问题和标准化合成通讯协定是市场成长的条件。创新的关键领域包括开发具有更高特异性和活性的新型酵素、整合用于序列优化的人工智慧增强设计工具以及改进合成製程的微流体技术进步。市场竞争激烈，但发展迅速，许多新兴企业和现有企业都以争夺市场占有率为目标，需要不断创新。对于希望利用这一成长的公司的研究提案包括投资研究合作、专注于具有成本效益和可扩展的生产方法，以及加强与学术机构的伙伴关係，以保持技术进步的前沿。使您的业务策略适应个人化医疗和永续生物技术解决方案的趋势对于永续成长和市场领导至关重要。

主要市场统计
基准年[2023] 48.7亿美元
预测年份 [2024] 53.7亿美元
预测年份 [2030] 98.2亿美元
复合年增长率（%） 10.51%

市场动态：快速发展的酵素 DNA 合成市场的关键市场洞察

供需的动态交互作用正在改变酵素 DNA 合成市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 在诊断和个人化医疗中使用合成 DNA 来改善患者预后
    • 基因组资料的扩展以及研究和临床环境中快速 DNA 合成的需求
    • 主要企业之间的策略联盟加速创新DNA合成解决方案的开发
    • 与传统方法相比，酶促 DNA 合成的成本效益和扩充性
  • 市场限制因素
    • 确保 DNA 酶合成的精确性和准确性的复杂性和技术挑战可能会导致潜在的错误和低效率
    • 酶促 DNA 合成技术的研发高成本，限制了其可近性和可负担性。
  • 市场机会
    • 製药公司越来越多地采用酵素法 DNA 合成进行药物开发和筛检
    • 一种创新的酶促 DNA 合成解决方案，可在合成生物学中快速原型製作DNA 构建体的原型
    • 高通量酶促DNA合成技术支援自订DNA序列的大规模生产
  • 市场挑战
    • 与 DNA 酶合成技术相关的监管障碍和合规问题
    • 由于与现有 DNA 合成技术的竞争，限制了酶法 DNA 合成的市场渗透

波特五力：驾驭酵素 DNA 合成市场的策略工具

波特的五力框架是了解酵素 DNA 合成市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解酵素法 DNA 合成市场的外部影响

外部宏观环境因素在塑造酵素 DNA 合成市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解酵素法 DNA 合成市场的竞争状况

酶 DNA 合成市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵酵素法DNA合成市场供应商绩效评估

FPNV定位矩阵是评估酵素DNA合成市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製酶促 DNA 合成市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，酶促 DNA 合成市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在诊断和个人化医疗中使用合成 DNA 以获得更好的患者治疗效果
      • 基因组资料的扩展以及研究和临床环境中快速 DNA 合成的需求
      • 主要参与者之间的策略合作加速创新 DNA 合成解决方案的开发
      • 与传统方法相比，酶促 DNA 合成的成本效益和扩充性
    • 抑制因素
      • 确保酶促 DNA 合成的精确性和准确性的复杂性和技术挑战可能会导致潜在的错误和低效率
      • 酶促 DNA 合成技术的研发成本高昂，限制了其可及性和可负担性
    • 机会
      • 製药公司在药物开发和筛检中更多地采用酵素法 DNA 合成
      • 创新的酶促 DNA 合成解决方案可实现合成生物学 DNA 结构的快速原型製作
      • 高通量酶促 DNA 合成技术，支援大规模生产客自订DNA 序列
    • 任务
      • 与 DNA 酶合成技术相关的监管障碍和合规问题
      • 来自成熟 DNA 合成技术的竞争限制了酶法 DNA 合成的市场渗透
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章酶法 DNA 合成市场：依技术分类

  • 液相合成
  • 基于微晶片的合成
  • 基于PCR的酶合成
  • 固相合成

第 7 章 酶法 DNA 合成市场：依组成部分

  • 试剂
    • 缓衝
    • 酵素
    • 核苷酸

第八章酶法 DNA 合成市场：依应用分类

  • 生物技术研究
  • 临床诊断
  • 药物发现
  • 治疗药物

第9章 美洲酶法DNA合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区酵素法DNA合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的酵素法 DNA 合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C059D

The Enzymatic DNA Synthesis Market was valued at USD 4.87 billion in 2023, expected to reach USD 5.37 billion in 2024, and is projected to grow at a CAGR of 10.51%, to USD 9.82 billion by 2030.

Enzymatic DNA synthesis is a transformative biotechnology that facilitates the production of DNA sequences using enzyme-catalyzed reactions, offering precision and efficiency over traditional chemical synthesis methods. The necessity for enzymatic DNA synthesis arises from its applications in personalized medicine, synthetic biology, and gene therapy, driven by increased demand for rapid and high-fidelity DNA construction. Applications extend to research laboratories, pharmaceutical companies, and agricultural biotechnology firms, where high throughput and specificity are critical. The end-use scope encompasses academic and industrial sectors specializing in genetic engineering, diagnostics, and drug development. Market growth is influenced by the expanding genomics market, rising investments in biotechnology research, and the need for sustainable and scalable DNA synthesis methods. Advances in enzyme engineering and automation enhance synthesis capabilities, creating opportunities for companies to offer differentiated solutions. A shift towards environmentally friendly biotech processes underscores potential opportunities in green synthesis technologies. Limitations include the technical challenges associated with enzyme engineering, concerns over the cost-effectiveness for large-scale production, and regulatory hurdles in healthcare applications. Furthermore, market growth is contingent on overcoming intellectual property issues and standardizing synthesis protocols. Critical areas of innovation include developing novel enzymes with improved specificity and activity, integrating AI-enhanced design tools for sequence optimization, and advancing microfluidic technologies for improved synthesis processes. The nature of the market is competitive but rapidly evolving, with numerous startups and established companies striving for market share, necessitating continual innovation. Recommendations for businesses seeking to leverage this growth include investing in research collaborations, focusing on cost-effective scalable production methods, and enhancing partnerships with academic institutions to stay at the forefront of technological advancements. Adapting business strategies to align with the trends in personalized medicine and sustainable biotechnology solutions will be crucial for sustained growth and market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 4.87 billion
Estimated Year [2024] USD 5.37 billion
Forecast Year [2030] USD 9.82 billion
CAGR (%) 10.51%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
    • Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
    • Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
    • Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
  • Market Restraints
    • Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
    • High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
  • Market Opportunities
    • Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
    • Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
    • High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
  • Market Challenges
    • Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
    • Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis

Porter's Five Forces: A Strategic Tool for Navigating the Enzymatic DNA Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enzymatic DNA Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enzymatic DNA Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enzymatic DNA Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enzymatic DNA Synthesis Market

A detailed market share analysis in the Enzymatic DNA Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enzymatic DNA Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enzymatic DNA Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enzymatic DNA Synthesis Market

A strategic analysis of the Enzymatic DNA Synthesis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enzymatic DNA Synthesis Market, highlighting leading vendors and their innovative profiles. These include Ansa Biotechnologies, BioCat, Bioneer, Camena Bioscience, Codex DNA, DNA Script, Eurofins Genomics, Evonetix, Genewiz, GenScript, Integrated DNA Technologies, Kuano, Molecular Assemblies, Neuex, Nuclera, OriGene Technologies, Sigma-Aldrich, Telesis Bio, Thermo Fisher Scientific, and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Enzymatic DNA Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Liquid-Phase Synthesis, Microchip-Based Synthesis, PCR Based Enzymatic Synthesis, and Solid-Phase Synthesis.
  • Based on Component, market is studied across Reagents. The Reagents is further studied across Buffers, Enzymes, and Nucleotides.
  • Based on Application, market is studied across Biotechnology Research, Clinical Diagnostics, Drug Discovery, and Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
      • 5.1.1.2. Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
      • 5.1.1.3. Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
      • 5.1.1.4. Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
      • 5.1.2.2. High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
      • 5.1.3.2. Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
      • 5.1.3.3. High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
      • 5.1.4.2. Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enzymatic DNA Synthesis Market, by Technology

  • 6.1. Introduction
  • 6.2. Liquid-Phase Synthesis
  • 6.3. Microchip-Based Synthesis
  • 6.4. PCR Based Enzymatic Synthesis
  • 6.5. Solid-Phase Synthesis

7. Enzymatic DNA Synthesis Market, by Component

  • 7.1. Introduction
  • 7.2. Reagents
    • 7.2.1. Buffers
    • 7.2.2. Enzymes
    • 7.2.3. Nucleotides

8. Enzymatic DNA Synthesis Market, by Application

  • 8.1. Introduction
  • 8.2. Biotechnology Research
  • 8.3. Clinical Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Therapeutics

9. Americas Enzymatic DNA Synthesis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Enzymatic DNA Synthesis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Enzymatic DNA Synthesis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ansa Biotechnologies
  • 2. BioCat
  • 3. Bioneer
  • 4. Camena Bioscience
  • 5. Codex DNA
  • 6. DNA Script
  • 7. Eurofins Genomics
  • 8. Evonetix
  • 9. Genewiz
  • 10. GenScript
  • 11. Integrated DNA Technologies
  • 12. Kuano
  • 13. Molecular Assemblies
  • 14. Neuex
  • 15. Nuclera
  • 16. OriGene Technologies
  • 17. Sigma-Aldrich
  • 18. Telesis Bio
  • 19. Thermo Fisher Scientific
  • 20. Twist Bioscience

LIST OF FIGURES

  • FIGURE 1. ENZYMATIC DNA SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENZYMATIC DNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENZYMATIC DNA SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MICROCHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PCR BASED ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023